A phase II multicenter single arm study of oral BGJ398 in adult patients with advanced or metastatic cholangiocarcinoma with FGFR2 gene fusions or other FGFR genetic alterations who failed or are intolerant to platinum-based chemotherapy
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
